脉络丛癌的诊疗现状及研究进展

doi:10.3760/cma.j.issn.1004-4221.2018.02.019

摘要
图/表
参考文献()
相关文章 (15)
点击分布统计
下载分布统计

全文: PDF (0 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS) 背景资料

摘要脉络丛癌是起源于脑室内脉络丛上皮细胞的较罕见的颅内原发肿瘤,为WHO Ⅲ级,多发生于儿童。其治疗策略以最大程度的安全手术切除为主,对术后辅助治疗的疗效一直存在争议。近年来研究提示对于次全切除的脉络丛癌患者,术后联合放疗、化疗可改善预后,延长生存。经检索近 15年相关文献,就脉络丛癌的诊疗现状及研究进展进行综述。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	常晓静
	薛晓英

关键词 ：脉络丛癌, 诊断, 治疗, 进展

Abstract：Choroid plexus carcinoma is a relatively rare primary intracranial malignant tumor which is derived from the choroid plexus epithelium. It is classified as World Health Organization (WHO) grade Ⅲ and mainly occurs in children. Currently, maximal surgical resection is still the main therapeutic strategy. The clinical efficacy of postoperative adjuvant therapies remains controversial. Recent studies have promoted that postoperative combination of radiotherapy and chemotherapy can enhance the clinical prognosis and prolong the survival time for choroid plexus carcinoma patients undergoing sub-radical resection. In this review, relevant articles published in the recent 15 years were retrieved to summarize the current status and research progress on the diagnosis and treatment of choroid plexus carcinoma.

Key words： Choroid plexus carcinoma Diagnosis Treatment Progress

收稿日期: 2017-02-24

通讯作者: 薛晓英,Email:xxy6412@163.com

引用本文:

常晓静,薛晓英. 脉络丛癌的诊疗现状及研究进展[J]. 中华放射肿瘤学杂志, 2018, 27(2): 210-213.

Chang Xiaojing,Xue Xiaoying. Current status and research progress on diagnosis and treatment of choroid plexus carcinoma[J]. Chinese Journal of Radiation Oncology, 2018, 27(2): 210-213.

链接本文:

http://journal12.magtechjournal.com/Jweb_fszlx/CN/10.3760/cma.j.issn.1004-4221.2018.02.019 或 http://journal12.magtechjournal.com/Jweb_fszlx/CN/Y2018/V27/I2/210

[1] Wolff JEA,Sajedi M,Brant R,et al. Choroid plexus tumours[J].Br J Cancer,2002,87(10):1086-1091.DOI:10.1038/sj.bjc.6600609.
[2] Jeibmann A,Wrede B,Peters O,et al. Malignant progression in choroid plexus papillomas[J].J Neurosurg,2007,107(S3):199-202.DOI:10.3171/PED-07/09/199.
[3] Wrede B,Liu P,Wolff JEA.Chemotherapy improves the survival of patients with choroid plexus carcinoma:a meta-analysis of individual cases with choroid plexus tumors[J].J Neurooncol,2007,85(3):345-351.DOI:10.1007/s11060-007-9428-x.
[4] Yoshida K,Sato K,Kitai R,et al. Coincident choroid plexus carcinoma and adrenocortical tumor in an infant[J].Brain Tumor Pathol,2013,30(2):104-108.DOI:10.1007/s10014-012-0112-2.
[5] Wilhelm M,Hirsch W,Merkenschlager A,et al. A rare case of congenital choroid plexus carcinoma[J].Pediatr Hematol Oncol,2012,29(7):643-646.DOI:10.3109/08880018.2012.710298.
[6] Joó GJ,Reiniger L,Papp C,et al. Intrauterine diagnosis and pathology of fetal choroid plexus carcinoma-a case study[J].Pathol Res Pract,2014,210(12):1156-1159.DOI:10.1016/j.prp.2014.01.009.
[7] Sun MZ,Oh MC,Ivan ME,et al. Current management of choroid plexus carcinomas[J].Neurosurg Rev,2014,37(2):179-192.DOI:10.1007/s10143-013-0499-1.
[8] Meyers SP,Khademian ZP,Chuang SH,et al. Choroid plexus carcinomas in children:MRI features and patient outcomes[J].Neuroradiology,2004,46(9):770-780.DOI:10.1007/s00234-004-1238-7.
[9] Mishra A,Srivastava C,Singh SK,et al. Choroid plexus carcinoma:case report and review of literature[J].J Pediatr Neurosci,2012,7(1):71-73.DOI:10.4103/1817-1745.97633.
[10] 高杰,于国,桂秋萍.脉络丛乳头状癌5例病理诊断及鉴别诊断[J].诊断病理学杂志,2008,15(2):92-95.DOI:10.3969/j.issn.1007-8096.2008.02.004.Gao J,Yu G,Gui QP.Pathological diagnosis and differential diagnosis of choroid plexus papillary carcinoma:a report of 5 cases[J].J Diagnostic Pathol,2008,15(2):92-95.DOI:10.3969/j.issn.1007-8096.2008.02.004.
[11] Savage NM,Crosby JH,Reid-Nicholson MD.The cytologic findings in choroid plexus carcinoma:report of a case with differential diagnosis[J].Diagn Cytopathol,2012,40(1):1-6.DOI:10.1002/dc.21478.
[12] Jaiswal S,Vij M,Mehrotra A,et al. Choroid plexus tumors:a clinico-pathological and neuro-radiological study of 23 cases[J].Asian J Neurosurg,2013,8(1):29-35.DOI:10.4103/1793-5482.110277.
[13] Shenoy AS,Desai HM.Choroid plexus carcinoma with hyaline globules:an unusual histological feature[J].Indian J Pathol Microbiol,2016,59(2):249-250.DOI:10.4103/0377-4929.182042.
[14] Tong YA,Merino D,Nimmervoll B,et al. Cross-species genomics identifies TAF12,NFYC,and RAD54L as choroid plexus carcinoma oncogenes[J].Cancer Cell,2015,27(5):712-727.DOI:10.1016/j.ccell.2015.04.005.
[15] Custodio G,Taques GR,Figueiredo BC,et al. Increased incidence of choroid plexus carcinoma due to the germline TP53 R337H mutation in southern Brazil[J].PLoS One,2011,6(3):e18015.DOI:10.1371/journal.pone.0018015.
[16] Tabori U,Shlien A,Baskin B,et al. TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors[J].J Clin Oncol,2010,28(12):1995-2001.DOI:10.1200/JCO.2009.26.8169.
[17] Wrede B,Liu P,Ater J,et al. Second surgery and the prognosis of choroid plexus carcinoma—results of a meta-analysis of individual cases[J].Anticancer Res,2005,25(6C):4429-4433.
[18] Sun MZ,Ivan ME,Clark AJ,et al. Gross total resection improves overall survival in children with choroid plexus carcinoma[J].J Neurooncol,2014,116(1):179-185.DOI:10.1007/s11060-013-1281-5.
[19] Passariello A,Tufano M,Spennato P,et al. The role of chemotherapy and surgical removal in the treatment of Choroid Plexus carcinomas and atypical papillomas[J].Childs Nerv Syst,2015,31(7):1079-1088.DOI:10.1007/s00381-015-2697-3.
[20] Menon G,Nair SN,Baldawa SS,et al. Choroid plexus tumors:an institutional series of 25 patients[J].Neurology India,2010,58(3):429-435.DOI:10.4103/0028-3886.66455.
[21] Gopal P,Parker JR,Debski R,et al. Choroid plexus carcinoma[J].Arch Pathol Lab Med,2008,132(8):1350-1354.
[22] St Clair SK,Humphreys RP,Pillay PK,et al. Current management of choroid plexus carcinoma in children[J].Pediatr Neurosurg,1991,17(5):225-233.
[23] Lafay-Cousin L,Mabbott DJ,Halliday W,et al. Use of ifosfamide,carboplatin,and etoposide chemotherapy in choroid plexus carcinoma[J].J Neurosurg Pediatr,2010,5(6):615-621.DOI:10.3171/2010.3.PEDS09354.
[24] Sun MZ,Ivan ME,Oh MC,et al. Effects of adjuvant chemotherapy and radiation on overall survival in children with choroid plexus carcinoma[J].J Neurooncol,2014,120(2):353-360.DOI:10.1007/s11060-014-1559-2.
[25] Bahar M,Kordes U,Tekautz T,et al. Radiation therapy for choroid plexus carcinoma patients with Li-Fraumeni syndrome:advantageous or detrimental?[J].Anticancer Res,2015,35(5):3013-3017.
[26] Hasselblatt M,Mühlisch J,Wrede B,et al. Aberrant MGMT (O6-methylguanine-DNA methyltransferase) promoter methylation in choroid plexus tumors[J].J Neurooncol,2009,91(2):151-155.DOI:10.1007/s11060-008-9694-2.
[27] Due-Tønnessen B,Helseth E,Skullerud K,et al. Choroid plexus tumors in children and young adults:report of 16 consecutive cases[J].Childs Nerv Syst,2001,17(4-5):252-256.
[28] Wolff JE,Sajedi M,Coppes MJ,et al. Radiation therapy and survival in choroid plexus carcinoma[J].Lancet,1999,353(9170):2126.
[29] Wrede B,Hasselblatt M,Peters O,et al. Atypical choroid plexus papilloma:clinical experience in the CPT-SIOP-2000 study[J].J Neurooncol,2009,95(3):383-392.DOI:10.1007/s11060-009-9936-y.
[30] Mazloom A,Wolff JE,Paulino AC.The impact of radiotherapy fields in the treatment of patients with choroid plexus carcinoma[J].Int J Radiat Oncol Biol Phys,2010,78(1):79-84.DOI:10.1016/j.ijrobp.2009.07.1701.
[31] Postovsky S,Vlodavsky E,Eran A,et al. Secondary glioblastoma multiforme after treatment for primary choroid plexus carcinoma in childhood[J].J Pediatr Hematol Oncol,2007,29(4):248-252.DOI:10.1097/MPH.0b013e31804a570b.
[32] Pellerino A,Cassoni P,Boldorini R,et al. Response to combined radiotherapy and chemotherapy of a leptomeningeal spread from choroid plexus carcinoma:case report[J].Neurol Sci,2015,36(4):639-641.DOI:10.1007/s10072-014-1983-2.
[33] Lozier AP,Arbaje YM,Scheithauer BW.Supratentorial,extraventricular choroid plexus carcinoma in an adult:case report[J].Neurosurgery,2009,65(4):E816-E817.DOI:10.1227/01.NEU.0000348291.48810.C2.
[34] Cuervo-Arango I,Reimunde P,Gutiérrez JC,et al. Choroid plexus tumour treatment at Hospital InfantilNiño Jesús in Madrid:our experience over the last three decades[J].Neurocirugia (Astur),2015,26(5):209-216.DOI:10.1016/j.neucir.2015.01.001.
[35] Berrak SG,Liu DD,Wrede B,et al. Which therapy works better in choroid plexus carcinomas?[J].J Neurooncol,2011,103(1):155-162.DOI:10.1007/s11060-010-0372-9.
[36] Misaki K,Nakada M,Mohri M,et al. MGMT promoter methylation and temozolomide response in choroid plexus carcinoma[J].Brain Tumor Pathol,2011,28(3):259-263.DOI:10.1007/s10014-011-0033-5.
[37] Schneider C,Kamaly-Asl I,Ramaswamy V,et al. Neoadjuvant chemotherapy reduces blood loss during the resection of pediatric choroid plexus carcinomas[J].J Neurosurg Pediatr,2015,16(2):126-133.DOI:10.3171/2014.12.PEDS14372.
[38] Mosleh O,Tabori U,Bartels U,et al. Successful treatment of a recurrent choroid plexus carcinoma with surgery followed by high-dose chemotherapy and stem cell rescue[J].Pediatr Hematol Oncol,2013,30(5):386-391.DOI:10.3109/08880018.2012.756089.
[39] Samuel TA,Parikh J,Sharma S,et al. Recurrent adult choroid plexus carcinoma treated with high-dose chemotherapy and syngeneic stem cell (bone marrow) transplant[J].J Neurol Surg A Cent Eur Neurosurg,2013,74 Suppl 1:e149-e154.DOI:10.1055/s-0032-1333419.